Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer

BACKGROUND: Bacillus Calmette Guérin (BCG)-immunotherapy has a well-documented and successful clinical history in the treatment of bladder cancer. However, regularly observed side effects, a certain degree of nonresponders and restriction to superficial cancers remain a major obstacle. Therefore, al...

Descripción completa

Detalles Bibliográficos
Autores principales: Sänger, Christian, Busche, Andreas, Bentien, Gabriele, Spallek, Ralf, Jonas, Fatima, Böhle, Andreas, Singh, Mahavir, Brandau, Sven
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544192/
https://www.ncbi.nlm.nih.gov/pubmed/15566565
http://dx.doi.org/10.1186/1471-2407-4-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544192/
https://www.ncbi.nlm.nih.gov/pubmed/15566565
http://dx.doi.org/10.1186/1471-2407-4-86

Ejemplares similares